Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > 99.9% High Purity Retatrutide Lyophilized White Powder Triple Agonist Peptide Raw Material
99.9% High Purity Retatrutide Lyophilized White Powder Triple Agonist Peptide Raw Material buy - large image1
99.9% High Purity Retatrutide Lyophilized White Powder Triple Agonist Peptide Raw Material buy - image1
99.9% High Purity Retatrutide Lyophilized White Powder Triple Agonist Peptide Raw Material buy - image2
99.9% High Purity Retatrutide Lyophilized White Powder Triple Agonist Peptide Raw Material buy - image3
99.9% High Purity Retatrutide Lyophilized White Powder Triple Agonist Peptide Raw Material buy - image4
99.9% High Purity Retatrutide Lyophilized White Powder Triple Agonist Peptide Raw Material buy - image5
99.9% High Purity Retatrutide Lyophilized White Powder Triple Agonist Peptide Raw Material buy - image6

99.9% High Purity Retatrutide Lyophilized White Powder Triple Agonist Peptide Raw Material

7282 Inquiries

Unit Price: Get Latest Price
CAS No.:

2381089-83-2

Content:

99.9%

Port:

HK

Brand:

HNYH

Packaging:

10mg/vial; 10vials/box

Sample Available:

Yes

Price valid (until):

2026-07-21

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P
Average Lead Time:
3 days
Qualification:
Main Products:

Retatrutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Contact me to get the quotation sheet.

     Name:Lynn 

    WhatsApp:+86 178 5417 5355

    Telegram:+86 178 5417 5355

    Product Introduction

    Shop 99.9% High Purity Retatrutide Lyophilized White Powder Triple Agonist Peptide Raw Material-Detailed Image 1

    Retatrutide, also known by its research code LY3437943, is a fully synthetic peptide compound with the CAS registry number 2381089-83-2. It consists of a 39-amino-acid single chain built on a modified GIP peptide backbone, integrated with two non-standard Aib residues and one α-methyl-L-leucine residue, plus a conjugated C20 fatty diacid side chain for structural stability. Its molecular formula is C₂₂₁H₃₄₂N₄₆O₆₈, with a precise molecular weight of 4731.33 g/mol.
    This peptide material is supplied exclusively as lyophilized white powder, sealed inside sterile glass vials without printed labels or embossed text on flat red caps as customized. Standard laboratory-grade batches achieve minimum 99% purity verified via HPLC testing, with full Certificates of Analysis provided for each production lot to document purity, moisture content, molecular identity and residual solvent data. The powder shows moderate hygroscopicity and light sensitivity, requiring strict moisture and UV shielding during storage and transportation.
    As a triple receptor agonist research material, Retatrutide is designed for in-vitro and laboratory animal model studies only, and is not authorized for human clinical medication, cosmetic manufacturing or food additive applications. Its core research value lies in simultaneous binding to GLP-1, GIP and glucagon receptors, allowing comparative analysis of multi-receptor signal pathways in metabolic research systems.

    Company Profile

    Shop 99.9% High Purity Retatrutide Lyophilized White Powder Triple Agonist Peptide Raw Material-Detailed Image 2

    Our company is a professional manufacturer specializing in the research, production and supply of various peptide raw materials. We have standardized independent production workshops and complete laboratory testing equipment to guarantee stable product quality. All peptide goods, including Retatrutide, Thymosin Alpha 1 and other synthetic peptides, are supplied as lyophilized white powder with HPLC purity above 99%. Each batch comes with a formal Certificate of Analysis for full data traceability.
    We strictly follow standardized production and packaging processes. Custom vial packaging without labels is available to meet clients’ experimental demands. Our team consists of professional chemical researchers who offer stable technical support for laboratory purchasers. All products are only for scientific research, not for human medical, food or cosmetic application. We maintain long-term cooperative relations with labs and raw material distributors worldwide, supporting flexible batch orders and secure low-temperature logistics to keep peptide molecular activity intact.



    Shop 99.9% High Purity Retatrutide Lyophilized White Powder Triple Agonist Peptide Raw Material-Detailed Image 3

    We deliver reliable worldwide shipping services to clients across every major continent, covering mainstream destinations such as New York, London, Tokyo, Dubai and many other cities. To achieve the fastest possible delivery lead time, we have established long-term cooperative partnerships with top international air freight carriers, enabling priority cargo scheduling to cut down transit periods greatly.
    Our professional logistics team optimizes transportation routes and streamlines customs clearance procedures in advance to avoid unnecessary delays. All peptide goods are packed with dedicated cold-resistant insulation packaging, which effectively stabilizes molecular activity during long-distance cross-border transport.
    No matter small trial samples or large bulk orders, we provide flexible shipping solutions to match your schedule. Our comprehensive global logistics network ensures consistent, speedy delivery to laboratories and distributors worldwide. We strictly track every shipment’s real-time logistics information and offer timely updates for customers, bringing efficient, secure and ultra-fast global delivery experience for all research material purchasers.

    Shipping Cost:

    Special Shipping Line/Express: $70 (under 5kg)
    Delivery time: 14 days
    UK: ~25 days (slightly delayed)
    UPS/FedEx, delivery time 7-10 days
    Shipping free if order is over $1000.
    *Some areas may be classified as remote areas by FedEx/UPS, potentially incurring an additional $35 remote area fee.*

    FAQ

    Q1: Can I get a sample before placing an order?
    Yes, samples are available upon request. Samples are not provided for free. You will need to pay for both the sample cost and the shipping fee. The sample fee will be deducted from your bulk order payment once you proceed with a formal order.
    Q2: What payment methods do you accept?
    We accept wire transfer (T/T), PayPal, and bank transfer. You may choose the most convenient method for you.
    Q3: How and when can I receive my order after payment?
    -Small quantity orders:** Shipped via international express (DHL, FedEx, UPS, etc.). Delivery time: 7-10 days after shipment.
    - Large quantity orders:** Shipped by sea. Delivery time: 15-30 days depending on the destination port.
    - Special line:** ~14 days delivery time (under 5kg, $40).
    Q4: Can I use my own label or packaging?
    Yes, OEM service is available for bulk orders. We can customize labels, vial dosage, vial cap color, and packaging according to your requirements.
    Q5: What is your MOQ?
    - Retail MOQ: 1 kit/dosage/item
    - Customized packaging (custom vial size, cap color): 20-50 kits/dosage/item
    - For CagriSema CS5: custom order, 20 boxes minimum
    Q6: Do you provide a Certificate of Analysis (COA)?
    Yes, each batch comes with a COA (HPLC purity test report). Third-party testing is also available upon request.
    Q7: How should I store the peptide?**
    Store at -20°C, protected from light, and keep sealed. Once reconstituted, refrigerate at 2-8°C and use within the recommended timeframe.

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Retatrutide

    Location:

    Lobby of Area B, Area E, Area F and Area G (Central Office Area), Landao Research Center, No.3 Yingbin Road, Yangpu Economic Development Zone, Hainan Province

    Payment Terms:

    TT against copy of documents,D/P

    Average lead Time:

    3 days

    Total Annual Revenue:

    $2.5 million-$5 million

    Total Employees:

    51-100

    Year of Establishment:

    2025

    Company Certificates
    • Hainan Yinghui Trading Co., Ltd.Retatrutide Retatrutide
    • Hainan Yinghui Trading Co., Ltd.Retatrutide Retatrutide
    • Hainan Yinghui Trading Co., Ltd.Retatrutide Retatrutide
    • Hainan Yinghui Trading Co., Ltd.Retatrutide Retatrutide
  • Inquiry History
    7282 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Australia

    GMP Grade 99% Retatrutide Lyophilized Powder CAS 2381089-83-2

    10 G Jun 12, 2026
    Hongkong, China

    Retatrutide CAS 2381089-83-2 safe delivery strong Lyophilized powder Vial

    20  Jan 25, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.